Target intelligence / Profile preview

Biotin

Molecular classification
Vitamin, Coenzyme, Organic compound, Organoheterocyclic compound, Small molecule
01

Overview

Biotin is a water-soluble vitamin (B7/H) with a fused ring structure (ureido and tetrahydrothiophene) and a valeric acid side chain, functioning as a coenzyme in carboxylase enzymes that mediate key steps in metabolism (fatty acid synthesis, breakdown of amino acids, gluconeogenesis). Found in most tissues and synthesized by intestinal bacteria, biotin deficiency often leads to metabolic and neurological disorders. Biotin’s tight binding to proteins like avidin/streptavidin facilitates its extensive use in biotechnology. It is not itself a direct target for pharmaceuticals, but it is essential for normal cellular physiology and is commonly included in vitamin supplements.

Other names
Vitamin B7Vitamin HHexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acidBiotine (French, Dutch)Biotina (Italian)Vitamina H (Italian)Biotyna (Polish)Vitamine B8 (French)
02

Mechanism of action

As a coenzyme, biotin binds carboxylase enzymes, facilitating transfer of CO₂ in metabolic reactions Non-drug mechanism of action: carrier for carboxylation reactions in metabolism In laboratory applications: biotin’s high-affinity binding to avidin/streptavidin is used in assays and molecular biology

03

Biological functions

Cofactor in carboxylase enzymesFatty acid synthesisBranched-chain amino acid catabolismGluconeogenesisChromatin structure regulation (histone biotinylation)Gene expression regulation
04

Disease associations

Deficiency leads to metabolic disorders (multiple carboxylase deficiency, skin rash, neurological symptoms)Congenital biotinidase deficiency (inborn error of metabolism)"Other" (no direct role in cancer, neurodegeneration, cardiovascular disease by itself, but impaired carboxylase function may be related to broader metabolic or developmental syndromes)
05

Safety considerations

Very low toxicity at nutritional dosesHigh-dose supplementation can interfere with laboratory tests for thyroid hormones and other immunoassaysDeficiency due to genetic biotinidase inactivity, poor diet, or certain medical conditions leads to symptoms, but biotin itself is not typically toxic
06

Interacting drugs

None – no drugs target biotin itself; it is sometimes used in combination vitamin therapies

1 more in the full profile.

07

Biomarkers

Blood biotin levels (used to assess deficiency)Urine and plasma carboxylase activityBiotinidase enzyme activity (for diagnosis of deficiency)

Beyond the preview

Go deeper on Biotin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call